» Articles » PMID: 32582015

Prior Stroke in PFO Patients Is Associated With Both PFO-Related and -Unrelated Factors

Abstract

To identify factors associated with prior stroke at presentation in patients with cryptogenic stroke (CS) and patent foramen ovale (PFO). We studied cross-sectional data from the International PFO Consortium Study (NCT00859885). Patients with first-ever stroke and those with prior stroke at baseline were analyzed for an association with PFO-related (right-to-left shunt at rest, atrial septal aneurysm, deep venous thrombosis, pulmonary embolism, and Valsalva maneuver) and PFO-unrelated factors (age, gender, BMI, hypertension, diabetes mellitus, hypercholesterolemia, smoking, migraine, coronary artery disease, aortic plaque). A multivariable analysis was used to adjust effect estimation for confounding, e.g., owing to the age-dependent definition of study groups in this cross-sectional study design. We identified 635 patients with first-ever and 53 patients with prior stroke. Age, BMI, hypertension, diabetes mellitus, hypercholesterolemia, coronary artery disease, and right-to-left shunt (RLS) at rest were significantly associated with prior stroke. Using a pre-specified multivariable logistic regression model, age (Odds Ratio 1.06), BMI (OR 1.06), hypercholesterolemia (OR 1.90) and RLS at rest (OR 1.88) were strongly associated with prior stroke.Based on these factors, we developed a nomogram to illustrate the strength of the relation of individual factors to prior stroke. In patients with CS and PFO, the likelihood of prior stroke is associated with both, PFO-related and PFO-unrelated factors.

Citing Articles

Ignored Role of Paroxysmal Atrial Fibrillation in the Pathophysiology of Cryptogenic Stroke in Patients with Patent Foramen Ovale and Atrial Septal Aneurysm.

Yetkin E, Atmaca H, Cuglan B, Yalta K Curr Cardiol Rev. 2024; 20(2):14-19.

PMID: 38367262 PMC: 11107473. DOI: 10.2174/011573403X267669240125041203.


[Thalamic infarction following paradoxical embolism during total hip replacement : Case report and pathophysiological considerations].

Brandt L, Albert S, Brandt K Anaesthesiologie. 2022; 71(7):535-540.

PMID: 35133444 DOI: 10.1007/s00101-022-01094-y.

References
1.
Friberg L, Rosenqvist M, Lip G . Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J. 2012; 33(12):1500-10. DOI: 10.1093/eurheartj/ehr488. View

2.
Vittinghoff E, McCulloch C . Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2006; 165(6):710-8. DOI: 10.1093/aje/kwk052. View

3.
Oesch L, Tatlisumak T, Arnold M, Sarikaya H . Obesity paradox in stroke - Myth or reality? A systematic review. PLoS One. 2017; 12(3):e0171334. PMC: 5349441. DOI: 10.1371/journal.pone.0171334. View

4.
Ahmad Y, Howard J, Arnold A, Shin M, Cook C, Petraco R . Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials. Eur Heart J. 2018; 39(18):1638-1649. PMC: 5946888. DOI: 10.1093/eurheartj/ehy121. View

5.
Sondergaard L, Kasner S, Rhodes J, Andersen G, Iversen H, Nielsen-Kudsk J . Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke. N Engl J Med. 2017; 377(11):1033-1042. DOI: 10.1056/NEJMoa1707404. View